MIM
LONA

MetLife Investment Management’s LeonaBio Inc LONA Stock Holding History

MetLife Investment Management’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,123
Closed -$287K – 2863
2022
Q1 		$287K Buy
2,123
+753
+55% +$79.4K ﹤0.01% 2122
2021
Q4 		$179K Buy
1,370
+632
+86% +$79.9K ﹤0.01% 2118
2021
Q3 		$69.2K Sell
738
-797
-52% -$81.1K ﹤0.01% 2514
2021
Q2 		$157K Buy
+1,535
New +$268K ﹤0.01% 2301
2021
Q1 		– Sell
-632
Closed -$216K – 2316
2020
Q4 		$216K Buy
+632
New +$149K ﹤0.01% 1944

Other funds holding LONA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BA
Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MetLife Investment Management's LONA Position: Q2 2022 in Review

MetLife Investment Management sold out of LeonaBio Inc (LONA) in Q2 2022, closing a stake of 2,123 shares — an estimated $287K sold.

MetLife Investment Management first reported a position in LONA in Q4 2020 and held it in 5 quarters. The position peaked at $287K in Q1 2022. 98 funds tracked by Wall St. Rank hold LONA as of Q2 2022.

  • MetLife Investment Management reported no remaining LeonaBio Inc position as of Q2 2022 after selling out during the quarter.
  • MetLife Investment Management sold 2,123 LeonaBio Inc shares in Q2 2022, an estimated $287K.
  • MetLife Investment Management first reported a position in LeonaBio Inc in Q4 2020 and held it in 5 quarters.
  • MetLife Investment Management's LeonaBio Inc position peaked at $287K in Q1 2022.
  • 98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2022.

Based on MetLife Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.